Authors: Jabs, WJ Hennig, H Kittel, M Pethig, K Smets, F Bucsky, P Kirchner, H Wagner, HJ

Citation: Wj. Jabs et al., Normalized quantification by real-time PCR of Epstein-Barr virus load in patients at risk for posttransplant lymphoproliferative disorders, J CLIN MICR, 39(2), 2001, pp. 564-569

Authors: Wagner, HJ Hennig, H Jabs, WJ Siekhaus, A Wessel, K Wandinger, KP

Citation: Hj. Wagner et al., Altered prevalence and reactivity of anti-Epstein-Barr virus antibodies inpatients with multiple sclerosis, VIRAL IMMUN, 13(4), 2000, pp. 497-502

Authors: Jabs, WJ Wagner, HJ Schlenke, P Kirchner, H

Citation: Wj. Jabs et al., The primary and memory immune response to Epstein-Barr virus infection in vitro is characterized by a divergent production of IL-1 beta/IL-6 and IL-10, SC J IMMUN, 52(3), 2000, pp. 304-308

Authors: Hennig, C Rink, L Fagin, U Jabs, WJ Kirchner, H

Citation: C. Hennig et al., The influence of naturally occurring heterophilic anti-immunoglobulin antibodies on direct measurement of serum proteins using sandwich ELISAs, J IMMUNOL M, 235(1-2), 2000, pp. 71-80

Authors: Jabs, WJ Hennig, C Zawatzky, R Kirchner, H

Citation: Wj. Jabs et al., Failure to detect antiviral activity in serum and plasma of healthy individuals displaying high activity in ELISA for IFN-alpha and IFN-beta, J INTERF CY, 19(5), 1999, pp. 463-469

Authors: Jabs, WJ Paulsen, M Wagner, HJ Kirchner, H Kluter, H

Citation: Wj. Jabs et al., Analysis of Epstein-Barr virus (EBV) receptor CD21 on peripheral B lymphocytes of long-term EBV- adults, CLIN EXP IM, 116(3), 1999, pp. 468-473